A National Danish Effectiveness Study of Ocrelizumab Versus Natalizumab in Multiple Sclerosis
{{output}}
Background: Ocrelizumab and natalizumab are highly effective disease-modifying treatments for relapsing-remitting multiple sclerosis (RRMS). Direct comparison of effectiveness is crucial for optimizing treatment decisions and imp... ...
